TCF7 and breast cancer: Mechanism study revealed that synthetic miR159 had the potential to inhibit the growth of breast cancer cells by aiming the region of nucleotide 1445-1470 and 1842-1870 in 3′UTR of TCF7, then resulting in the decrease of MYC protein levels.